From day 0 to day 7, a significant induction of the inflammasome pathway genes, which included NLRC4, NLRP1, CASP1, PYCARD, and IL-18, was detected in COVID-19+ individuals compared to healthy controls. This evidence concerns the gene NLRC4 and COVID-19.